Physician

Afshin Salsali, MD

According to 2025 Medicare claims, Afshin Salsali, MD (NPI: 1841372554) practices endocrinology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Middlesex, NJ. This provider's primary affiliated billing organization is RUTGERS HEALTH-RWJ SCLERODERMA PROGRAM (NPI: 1720113616; TIN: 223371727) and primary practice location at 08901-1962. Salsali is affiliated with the Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Salsali's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 11 traditional Medicare patients, billed 19 HCPCS/CPT codes, and received $2,038 in Medicare payments. Part D data shows 172 prescription claims across 20 beneficiaries totaling $114,121 in drug costs, led by Afrezza (Insulin Regular, Human). 2023 DME data shows 19 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $25,328 to $114,121. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.2K$2.4K2015 Medicare payment: $2,398 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,734 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,412 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,038 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151331$2,398
20161428$1,734
20171122$1,412
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
20241119$2,038

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$75K$150K2015 Drug cost: $25,328 (USD; Tot_Drug_Cst)2016 Drug cost: $50,099 (USD; Tot_Drug_Cst)2017 Drug cost: $46,974 (USD; Tot_Drug_Cst)2018 Drug cost: $26,505 (USD; Tot_Drug_Cst)2019 Drug cost: $56,221 (USD; Tot_Drug_Cst)2020 Drug cost: $34,029 (USD; Tot_Drug_Cst)2021 Drug cost: $88,617 (USD; Tot_Drug_Cst)2022 Drug cost: $92,278 (USD; Tot_Drug_Cst)2023 Drug cost: $149,650 (USD; Tot_Drug_Cst)2024 Drug cost: $114,121 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R26$25,328
20161174$50,099
20171364$46,974
2018N/R23$26,505
2019N/R40$56,221
20201279$34,029
202113125$88,617
20221398$92,278
202320138$149,650
202420172$114,121

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$1.8K$3.6K2017 Medicare payment: $328 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $2,802 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $3,621 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R28$328
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/R15$2,802
2023N/R19$3,621
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Part B summary data is connected for 2024, but public code-level payment amounts are not available, so a Top 5 by total payments cannot be shown.

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
AfrezzaInsulin Regular, Human19951$47,087
OzempicSemaglutide17656$22,501
Levothyroxine SodiumLevothyroxine Sodium15965$174
Metformin HclMetformin Hcl14875$103

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Afshin Salsali, MD?

Tedicare shows public-source Medicare data for Afshin Salsali, MD (NPI 1841372554), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Afshin Salsali, MD have ACO affiliation data?

Afshin Salsali, MD is shown with ACO affiliation data for Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Afshin Salsali, MD?

Afshin Salsali, MD is linked to RUTGERS HEALTH-RWJ SCLERODERMA PROGRAM (billing NPI 1720113616) in the available physician profile data.

Does Afshin Salsali, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.